Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
13)/t9-/m1/s1
5-dimethyloxan-2-yl]-3'-methyl-[2
Formula: C27H30F3N9O
and inhibits the production of interleukin-1 (IL-1)
Formula: C20H20N8O4S
Sunitinib Malate Size:Solid 2 mg 13)/t9-/m1/s1Sunitinib, also known as SU11248, is the orally bioavailable malate salt of an indolinone based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet derived
US$ 147.58
US$ 141.26
US$ 264.00
US$ 264.00
US$ 147.58
US$ 117.30
US$ 243.09
US$ 190.05
US$ 126.47
US$ 132.84
US$ 117.30
US$ 117.30
US$ 231.00
US$ 147.58
US$ 188.90
US$ 126.47
US$ 197.07
US$ 404.05
US$ 126.47